THE USE OF MAGNETIC BEADS COATED WITH SOLUBLE HLA CLASS I OR CLASS II PROTEINS IN ANTIBODY SCREENING AND FOR SPECIFICITY DETERMINATION OF DONOR-REACTIVE ANTIBODIES1

1996 ◽  
Vol 61 (10) ◽  
pp. 1539-1545 ◽  
Author(s):  
Suchitra Sumitran-Karuppan ◽  
Erna M??ller
2008 ◽  
Vol 51 (3) ◽  
pp. 301-304 ◽  
Author(s):  
M. Ott ◽  
K. Stecker ◽  
C. Seidl ◽  
E. Seifried ◽  
U. Westhoff ◽  
...  

Blood ◽  
1999 ◽  
Vol 93 (5) ◽  
pp. 1770-1777 ◽  
Author(s):  
M. Ghio ◽  
P. Contini ◽  
C. Mazzei ◽  
S. Brenci ◽  
G. Barberis ◽  
...  

Abstract The immunomodulatory effect of allogeneic blood transfusions (ABT) has been known for many years. However, a complete understanding of the effects of ABT on the recipient’s immune system has remained elusive. Soluble HLA class I (sHLA-I), HLA class II (sHLA-II), and Fas ligand (sFasL) molecules may play immunoregulatory roles. We determined by double-determinant immunoenzymatic assay (DDIA) sHLA-I, sHLA-II, and sFasL concentrations in different blood components. sHLA-I and sFasL levels in red blood cells (RBCs) stored for up to 30 days and in random-donor platelets are significantly (P < .001) higher than in other blood components and their amount is proportionate to the number of residual donor leukocytes and to the length of storage. Blood components with high sHLA-I and sFasL levels play immunoregulatory roles in vitro as in allogeneic mixed lymphocyte responses (MLR) and antigen-specific cytotoxic T-cell (CTL) activity, and induce apoptosis in Fas-positive cells. These data suggest that soluble molecules in blood components are functional. If these results are paralleled in vivo, they should be taken into account in transfusion practice. Blood components that can cause immunosuppression should be chosen to induce transplantation tolerance, whereas blood components that lack immunosuppressive effects should be preferred to reduce the risk of postoperative complications and cancer recurrence.


Blood ◽  
1999 ◽  
Vol 93 (5) ◽  
pp. 1770-1777 ◽  
Author(s):  
M. Ghio ◽  
P. Contini ◽  
C. Mazzei ◽  
S. Brenci ◽  
G. Barberis ◽  
...  

The immunomodulatory effect of allogeneic blood transfusions (ABT) has been known for many years. However, a complete understanding of the effects of ABT on the recipient’s immune system has remained elusive. Soluble HLA class I (sHLA-I), HLA class II (sHLA-II), and Fas ligand (sFasL) molecules may play immunoregulatory roles. We determined by double-determinant immunoenzymatic assay (DDIA) sHLA-I, sHLA-II, and sFasL concentrations in different blood components. sHLA-I and sFasL levels in red blood cells (RBCs) stored for up to 30 days and in random-donor platelets are significantly (P < .001) higher than in other blood components and their amount is proportionate to the number of residual donor leukocytes and to the length of storage. Blood components with high sHLA-I and sFasL levels play immunoregulatory roles in vitro as in allogeneic mixed lymphocyte responses (MLR) and antigen-specific cytotoxic T-cell (CTL) activity, and induce apoptosis in Fas-positive cells. These data suggest that soluble molecules in blood components are functional. If these results are paralleled in vivo, they should be taken into account in transfusion practice. Blood components that can cause immunosuppression should be chosen to induce transplantation tolerance, whereas blood components that lack immunosuppressive effects should be preferred to reduce the risk of postoperative complications and cancer recurrence.


2001 ◽  
Vol 13 (6) ◽  
pp. 427 ◽  
Author(s):  
Simon Vassiliadis ◽  
Michael Paflis ◽  
Irene Athanassakis

The levels of maternal immunostimulation (required throughout the gestation period) and immunosuppression (needed from the 8th week to labour), as assessed by the mixed lymphocyte reaction (MLR), have been successfully correlated with the outcome of pregnancy. Our laboratory has recently reported that serum-soluble human leucocyte antigen (HLA) class I and II concentrations can be predictive for successful pregnancy outcome. In fact, there is a direct correlation between soluble class II concentrations and maternal immunostimulation because, as expected, these serum HLA concentrations are augmented in the first and second trimester of pregnancy and remain stable thereafter. By the same token, serum HLA class I concentrations are low during the first trimester, correlating with the required absence of immunosuppression, whereas they increase in subsequent trimesters as suppression becomes desirable for counteracting the maternal stimulation, which may otherwise become dangerous to the fetus. In this study, we present biological and statistical evidence that both states of maternal immunostimulation and immunosuppression, reflected by serum soluble HLA class II and class I antigens, do correlate with results obtained by standard MLR and can be predictive of pregnancy failure. The establishment of statistically significant correlations renders the measurement of soluble HLA a reliable test for determining the immunological status of the gestating woman. The unambiguous advantage of such an approach is that soluble HLA testing will no longer require the 1 week delay necessary to obtain MLR results, a period occasionally crucial for applying treatment to women whose immunological indices call for immediate therapeutic intervention.


2011 ◽  
Vol 44 (13) ◽  
pp. S280
Author(s):  
Mitra Masoudian ◽  
Mahmoud Mahmoudi ◽  
Maryam Rastin ◽  
Mohammadreza Hatef ◽  
Zhale Shariati ◽  
...  

1992 ◽  
Vol 39 (2) ◽  
pp. 74-77 ◽  
Author(s):  
H. Grosse-Wilde ◽  
R. Blasczyk ◽  
U. Westhoff
Keyword(s):  
Class Ii ◽  
Class I ◽  

Vox Sanguinis ◽  
1995 ◽  
Vol 68 (2) ◽  
pp. 73-76 ◽  
Author(s):  
Ulrike Westhoff ◽  
Hans Grosse-Wilde
Keyword(s):  
Class Ii ◽  
Class I ◽  

Sign in / Sign up

Export Citation Format

Share Document